21
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Roles of polyunsaturated fatty acids, from mediators to membranes

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          PUFAs, such as AA and DHA, are recognized as important biomolecules, but understanding their precise roles and modes of action remains challenging. PUFAs are precursors for a plethora of signaling lipids, for which knowledge about synthetic pathways and receptors has accumulated. However, due to their extreme diversity and the ambiguity concerning the identity of their cognate receptors, the roles of PUFA-derived signaling lipids require more investigation. In addition, PUFA functions cannot be explained just as lipid mediator precursors because they are also critical for the regulation of membrane biophysical properties. The presence of PUFAs in membrane lipids also affects the functions of transmembrane proteins and peripheral membrane proteins. Although the roles of PUFAs as membrane lipid building blocks were difficult to analyze, the discovery of lysophospholipid acyltransferases (LPLATs), which are critical for their incorporation, advanced our understanding. Recent studies unveiled how LPLATs affect PUFA levels in membrane lipids, and their genetic manipulation became an excellent strategy to study the roles of PUFA-containing lipids. In this review, we will provide an overview of metabolic pathways regulating PUFAs as lipid mediator precursors and membrane components and update recent progress about their functions. Some issues to be solved for future research will also be discussed.

          Related collections

          Most cited references100

          • Record: found
          • Abstract: found
          • Article: not found

          ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition.

          Ferroptosis is a form of regulated necrotic cell death controlled by glutathione peroxidase 4 (GPX4). At present, mechanisms that could predict sensitivity and/or resistance and that may be exploited to modulate ferroptosis are needed. We applied two independent approaches-a genome-wide CRISPR-based genetic screen and microarray analysis of ferroptosis-resistant cell lines-to uncover acyl-CoA synthetase long-chain family member 4 (ACSL4) as an essential component for ferroptosis execution. Specifically, Gpx4-Acsl4 double-knockout cells showed marked resistance to ferroptosis. Mechanistically, ACSL4 enriched cellular membranes with long polyunsaturated ω6 fatty acids. Moreover, ACSL4 was preferentially expressed in a panel of basal-like breast cancer cell lines and predicted their sensitivity to ferroptosis. Pharmacological targeting of ACSL4 with thiazolidinediones, a class of antidiabetic compound, ameliorated tissue demise in a mouse model of ferroptosis, suggesting that ACSL4 inhibition is a viable therapeutic approach to preventing ferroptosis-related diseases.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Understanding the diversity of membrane lipid composition

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Fatty acid transporter 2 reprograms neutrophils in cancer

              Summary Polymorphonuclear myeloid derived suppressor cells (PMN-MDSC) are pathologically activated neutrophils that are critically important for the regulation of immune responses in cancer. They contribute to the failure of cancer therapies and are associated with poor clinical outcomes. Despite the recent advances in understanding of the PMN-MDSC biology, the mechanisms responsible for pathological activation of neutrophils are not well defined, which limits selective targeting of these cells. Here, we report that mouse and human PMN-MDSC exclusively up-regulate fatty acid transporter protein 2 (FATP2). Over-expression of FATP2 in PMN-MDSC was controlled by GM-CSF, through the activation of STAT5 transcription factor. Deletion of FATP2 abrogated the suppressive activity of PMN-MDSC. The main mechanism of FATP2 mediated suppressive activity involved uptake of arachidonic acid (AA) and synthesis of prostaglandin E2 (PGE2). The selective pharmacological inhibition of FATP2 abrogated the activity of PMN-MDSC and substantially delayed tumor progression. In combination with check-point inhibitors it blocked tumor progression in mice. Thus, FATP2 mediates acquisition of immune suppressive activity by PMN-MDSC and represents a new target to selectively inhibit the functions of PMN-MDSC and improve the effect of cancer therapy.
                Bookmark

                Author and article information

                Journal
                J Lipid Res
                J. Lipid Res
                jlr
                jlr
                jlr
                Journal of Lipid Research
                The American Society for Biochemistry and Molecular Biology
                0022-2275
                1539-7262
                August 2020
                2 June 2020
                2 June 2020
                : 61
                : 8
                : 1150-1160
                Affiliations
                [* ]Department of Biochemistry and National Centre of Competence in Research in Chemical Biology, University of Geneva , CH-1211 Geneva, Switzerland
                []Department of Lipid Signaling, National Center for Global Health and Medicine , Shinjuku-ku, Tokyo 162-8655, Japan and Department of Lipidomics, Graduate School of Medicine, University of Tokyo , Bunkyo-ku, Tokyo 113-0033, Japan
                Author notes
                [1 ]To whom correspondence should be addressed. e-mail: harayama-t@ 123456umin.net (T.H); tshimizu@ 123456ri.ncgm.go.jp (T.S.)
                Author information
                https://orcid.org/0000-0003-2235-4197
                https://orcid.org/0000-0002-9097-1357
                Article
                r120000800
                10.1194/jlr.R120000800
                7397749
                32487545
                f62bc11f-291d-4feb-bd43-ba14872c12e1
                Copyright © 2020 Harayama and Shimizu. Published by The American Society for Biochemistry and Molecular Biology, Inc.

                Author’s Choice—Final version open access under the terms of the Creative Commons CC-BY license.

                History
                : 31 March 2020
                : 28 May 2020
                Funding
                Funded by: Japan Agency for Medical Research and Development, open-funder-registry 10.13039/100009619;
                Funded by: Takeda Science Foundation, open-funder-registry 10.13039/100007449;
                Funded by: Swiss National Science Foundation, open-funder-registry 10.13039/501100001711;
                Funded by: Japan Society for the Promotion of Science, open-funder-registry 10.13039/501100001691;
                Categories
                Reviews

                Biochemistry
                membrane biology,eicosanoids,g protein-coupled receptors,membrane biophysics,glycerophospholipids

                Comments

                Comment on this article